• +86-0635-6175299
  • li_ye@inyelchem.com
  • Firmendetails

 Shandong Haohong Biotechnology Co., Ltd.

Alle
  • Alle
  • Titel
Alle
  • Alle
  • Titel
Zuhause> Blog
May 19, 2021
Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination

May 19, 2021
FDA approves larotrectinib for solid tumors with NTRK gene fusions

On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VIT

April 01, 2021
COVID-19 Vaccine: Surmounting Prejudices and Other Roadblocks

Against all odds and contrary to expectations, Nigeria recently joined a few other African

April 01, 2021
FDA approves new treatment for a type of late stage prostate cancer

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat

April 01, 2021
Enzalutamide

Enzalutamide (Xtandi

April 01, 2021
Enzalutamide or abiraterone?

Enzalutamide and abiraterone are both types of hormone therapy that treat advanced prostate cancer.

Zuhause

Product

Phone

Über uns

Anfrage

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

senden